I have read with interest this article from Jones et al. I am however
slightly confused by the Conclusion. It states that "Indirect evidence
leads the authors to recommend the use of atropine during septic and late
hypovolaemic shock, when using suxamethonium." This implies atropine
should only be used in hypovolaemic states when suxamethonium is being
used, while I have read the body of the article to support the conclusion
that "Indirect evidence leads the authors to recommend the use of atropine
during septic and late hypovolaemic shock, or when using suxamethonium."
Apologies if I am mistaken?
Conflict of Interest:
None declared
I have read with interest this article from Jones et al. I am however slightly confused by the Conclusion. It states that "Indirect evidence leads the authors to recommend the use of atropine during septic and late hypovolaemic shock, when using suxamethonium." This implies atropine should only be used in hypovolaemic states when suxamethonium is being used, while I have read the body of the article to support the conclusion that "Indirect evidence leads the authors to recommend the use of atropine during septic and late hypovolaemic shock, or when using suxamethonium." Apologies if I am mistaken?
Conflict of Interest:
None declared